glp-1 therapies success rate Proportion of Patients Who Discontinued RA Therapy, n=4791 The Biggest Winner of GLP-1

These effects are typically most pronounced when starting treatment or increasing the dose

GLP-1 medications are being studied for an expanding range of conditions including autoimmune conditions , cardiovascular risk reduction, non-alcoholic fatty liver disease, and neurodegenerative diseases

Mol Biol Cell2010 Mar 1;21(5):833-41

Most major insurance companies have coverage for Zepbound, but your doctor may need to submit a prior authorization approval form to gain access

Despite the significant role Mojsov played in this work, MGH failed to recognise her contribution in the first patents they took out on GLP-1

1 , e00009 (2018)